Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases, Female

Explore clinical trials studying Genital Diseases, Female. Study availability and eligibility vary by location and protocol.

7,663 public trials 1,507 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases, Female trial results

Recruiting

Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

NCT07225270

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • Mt. Sinai Comprehensive Cancer Center Miami, Florida, United States
  • Sarasota Memorial Health Care System Sarasota, Florida, United States
  • Miami Valley Hospital South Centerville, Ohio, United States
  • Zangmeister Cancer Center Columbus, Ohio, United States
View all 16 locations
View Trial Details
Recruiting

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

NCT07702292

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Bergamo, Lombardy, Italy
  • Fondazione IRCCS San Gerardo dei Tintori Monza, Lombardy, Italy
  • Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore Roma, Italy
  • IRCCS Ospedale San Raffaele Milan, Segrate, Italy
View Trial Details
Recruiting

A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)

NCT07286266

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • GSK Investigational Site Randwick, New South Wales, Australia
  • GSK Investigational Site Montreal, Quebec, Canada
  • GSK Investigational Site Montreal, Quebec, Canada
  • GSK Investigational Site Hyōgo, Japan
View Trial Details
Recruiting

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer

NCT07278336

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Sarah Cannon Research Institute at HealthONE /ID# 278785 Denver, Colorado, United States
  • University of Chicago Medical Center /ID# 278295 Chicago, Illinois, United States
  • NEXT Oncology - San Antonio /ID# 278606 San Antonio, Texas, United States
  • Start Mountain Region /ID# 278609 West Valley City, Utah, United States
View all 17 locations
View Trial Details
Recruiting

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

NCT05640999

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Alaska Womens Cancer Care Anchorage, Alaska, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Huntington Memorial Hospital Pasadena, California, United States
View all 114 locations
View Trial Details
Recruiting

Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT04606914

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • University of Alabama at Birmingham Womens & Infants Center Birmingham, Alabama, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Minnesota - Masonic Cancer Center Minneapolis, Minnesota, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details

Related conditions